Bioxytran, Inc. (BIXT) Financial Statements (2024 and earlier)

Company Profile

Business Address C/O BIOXYTRAN, INC.
NEEDHAM, MA 02494
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26,086295,40172,35841,688169,62836,411
Cash and cash equivalents26,086295,40172,35841,688169,62836,411
Receivables     50,000 
Prepaid expense    274,715  
Total current assets:26,086295,40172,358316,403219,62836,411
Noncurrent Assets
Intangible assets, net (including goodwill)111,55275,53546,93210,000  
Intangible assets, net (excluding goodwill)111,55275,53546,93210,000  
Total noncurrent assets:111,55275,53546,93210,000  
TOTAL ASSETS:137,638370,936119,290326,403219,62836,411
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:296,312749,395624,316348,12771,93223,447
Interest and dividends payable   3,722
Taxes payable   400
Accounts payable    6677,251150
Accrued liabilities294,654748,405375,37184,32542,96319,175
Other undisclosed accounts payable and accrued liabilities1,658990248,945263,13521,718 
Debt1,900,0002,165,0002,122,1811,612,356850,983227,378
Deferred compensation liability  960    
Due to related parties709,727531,000307,17696,00010,900
Other undisclosed current liabilities1,053,18838,400    
Total current liabilities:3,249,5003,663,4823,277,4972,267,6591,018,915261,725
Noncurrent Liabilities
Total liabilities:3,249,5003,663,4823,277,4972,267,6591,018,915261,725
Equity
Equity, attributable to parent, including:(2,430,976)(2,701,918)(3,158,207)(1,941,256)(799,287)(225,314)
Common stock145,642123,252110,84197,45186,47685,104
Additional paid in capital12,920,9848,392,4305,881,8761,795,1251,355,54272,412
Accumulated deficit(15,497,602)(11,217,600)(8,753,668)(4,721,923)(2,241,305)(382,830)
Other undisclosed equity, attributable to parent   (397,256)888,091  
Equity, attributable to noncontrolling interest(680,886)(590,628)    
Total equity:(3,111,862)(3,292,546)(3,158,207)(1,941,256)(799,287)(225,314)
TOTAL LIABILITIES AND EQUITY:137,638370,936119,290326,403219,62836,411

Income Statement (P&L) (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(3,820,147)(2,134,112)(4,214,434)(1,268,701)(1,631,467) 
Operating loss:(3,820,147)(2,134,112)(4,214,434)(1,268,701)(1,631,467) 
Nonoperating expense(550,113)(523,192)(313,608)(1,273,826)(227,009)(81,307)
Interest and debt expense   (236,577)(1,014,769)(41,846)(8,375)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   236,5771,014,76941,846(206,335)
Loss from continuing operations before income taxes:(4,370,260)(2,657,304)(4,528,042)(2,542,527)(1,858,476)(296,017)
Income tax expense      (400)
Loss from continuing operations:(4,370,260)(2,657,304)(4,528,042)(2,542,527)(1,858,476)(296,417)
Loss before gain (loss) on sale of properties:(4,528,042)(2,542,527)(1,858,476)(296,417)
Other undisclosed net income   496,29761,909  
Net loss:(4,370,260)(2,657,304)(4,031,745)(2,480,618)(1,858,476)(296,417)
Net income attributable to noncontrolling interest90,258193,372496,29761,909  
Other undisclosed net loss attributable to parent   (992,594)(123,818)  
Net loss attributable to parent:(4,280,002)(2,463,932)(4,528,042)(2,542,527)(1,858,476)(296,417)
Other undisclosed net income available to common stockholders, basic   496,297   
Net loss available to common stockholders, diluted:(4,280,002)(2,463,932)(4,031,745)(2,542,527)(1,858,476)(296,417)

Comprehensive Income (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(4,370,260)(2,657,304)(4,031,745)(2,480,618)(1,858,476)(296,417)
Comprehensive loss:(4,370,260)(2,657,304)(4,031,745)(2,480,618)(1,858,476)(296,417)
Comprehensive income, net of tax, attributable to noncontrolling interest90,258193,372496,29761,909  
Comprehensive loss, net of tax, attributable to parent:(4,280,002)(2,463,932)(3,535,448)(2,418,709)(1,858,476)(296,417)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: